Navigation Links
Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
Date:8/19/2008

DURHAM, N.C., Aug. 19 /PRNewswire/ -- Addrenex Pharmaceuticals ( http://www.addrenex.com ) has made three strategic hires this month to further its goal of identifying and developing as many new drug candidates as possible over the next 18 months.

The fast-paced timeline they have set for drug discovery mirrors the company's recent successes in developing two new drugs, Clonicel(R) for attention deficit/hyperactivity disorder and CloniBID for hypertension, over the past two years. A new drug application has already been filed for CloniBID, with Food and Drug Administration review expected by December 2008, and Clonicel is in phase 3 clinical trials. Commercial rights to both drugs have been granted to Atlanta-based Sciele Pharma.

The additions of Steven Butts, M.B.A., as vice president of commercial operations and Gary Bream, Ph.D., as senior director of scientific affairs will strengthen Addrenex's ability to pursue additional drugs to treat conditions such as menopausal flushing, pain, addiction, aggression, and post traumatic stress disorder, said Moise Khayrallah, Ph.D., cofounder and chief executive officer of Addrenex. Yuki Prescott has also joined as clinical trials manager and will enhance the clinical team's ability to oversee a growing clinical program.

"We now have a solid partnership in place with Sciele that will enable us to develop our lead compounds and to pursue additional compounds in our portfolio that target the alpha-2 adrenergic receptors," said Khayrallah. "We're using our lead compounds to power the rest of the portfolio. The highly skilled team we have now assembled gives us the capability to deliver on our commitments and meet our fast-paced timelines."

The indications being targeted by Addrenex are each associated with an overactive adrenergic system, a group of hormones produced by the adrenal glands that regulate the body's reaction to stress, hormonal
'/>"/>

SOURCE Addrenex Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
2. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
5. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
6. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
7. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
8. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
9. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
10. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
11. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB ... composition of matter, biological targets, mechanism of action, methods ... This patent application describes a novel class ... which interfere with the basic homeostatic cellular processes in ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness & ... Center by the Medical Fitness Association, a non-profit organization ... their full potential. The Cadence Fitness & Health Center ... suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
(Date:7/9/2014)... research into the metabolism of stromal support cells and ... of these cell types in the development of diseases ... conditions and cancer. That was the conclusion of a ... in the leading journal Nature . , Prof. ... wake-up call. The metabolism of cancer cells has been ...
(Date:7/9/2014)... found that fecal transplantation is effective and safe for ... is the result of a study led by Colleen ... Gastrointestinal Medicine at The Women,s Medicine Collaborative. The study ... of print in the American Journal of Gastroenterology ... diff , has increased to epidemic proportions over the ...
(Date:7/9/2014)... The Miriam Hospital have found that people with ... depressed have difficulty sticking to a pulmonary rehabilitation ... women, and screening and brief treatment of depression ... study and its findings are published in print ... obstructive pulmonary disease is a common and often ...
(Date:7/9/2014)... news release is available in French . ... factors in 14 year old teens, including brain structure and ... 70% accuracy who will go on to develop binge drinking ... of conscientiousness, and other variables such as life events and ... of binge drinking. Whether or not the child had ...
(Date:7/9/2014)... Researchers from Montefiore Medical Center and ... Yeshiva University will present new findings at the Alzheimer,s ... July 17 in Copenhagen, Denmark. Data from the four ... from cognitive normality to mild cognitive impairment and dementia. ... Study , established in 1980 to examine healthy brain ...
Breaking Medicine News(10 mins):Health News:Wake-up call for more research into cell metabolism 2Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:Miriam Hospital study examines effect of depressed mood on pulmonary rehab completion 2Health News:What drives a child to abuse alcohol? 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3
... antidepressants, effectiveness , , THURSDAY, April 17 (HealthDay News) -- ... brain cells to their more plastic youthful condition in ... provides a possible new explanation for the antidepressant activity ... that it could be used to treat other conditions ...
... Funds Awarded to Reconstruct Devastating,Injuries;, Not all ... April 17 Members of,the American Society of ... the next five years developing groundbreaking therapies to ... Afghanistan. The U.S.,Department of Defense (DoD) has awarded ...
... Known Risks of Lead Paint in,Products Sourced in China, ... WASHINGTON, April 17 Based on a review of ... for 2006,and 2007, major industrial and other sectors affected ... informing shareholders of market risks they,face due to toxic ...
... 17 MSA (NYSE: MSA ), the,global leader ... protect people,s health and safety, announced today that it,will ... via the,Internet on Thursday, May 1, 2008 at 10:00 ... Investors and interested parties will have the opportunity to ...
... other diseases that affect red blood cells , , THURSDAY, April ... skin, says a new study that showed the skin plays ... and in stimulating kidney production of the hormone erythropoietin (EPO) ... blood cells that carry and deliver oxygen throughout the body. ...
... Nearly 20 percent of military service members who have ... -- report symptoms of post traumatic stress disorder or ... sought treatment, according to a new RAND Corporation study. ... returning service members report that they experienced a possible ...
Cached Medicine News:Health News:Prozac Makes Old Brain Cells Young 2Health News:Prozac Makes Old Brain Cells Young 3Health News:Plastic Surgeons Play Pivotal Role in War Injury Research 2Health News:Plastic Surgeons Play Pivotal Role in War Injury Research 3Health News:'Toxic Stock Syndrome' Report: Many Companies Are Keeping Shareholders in the Dark on Potential Recalls, Bans, and Other Risks 2Health News:'Toxic Stock Syndrome' Report: Many Companies Are Keeping Shareholders in the Dark on Potential Recalls, Bans, and Other Risks 3Health News:'Toxic Stock Syndrome' Report: Many Companies Are Keeping Shareholders in the Dark on Potential Recalls, Bans, and Other Risks 4Health News:'Toxic Stock Syndrome' Report: Many Companies Are Keeping Shareholders in the Dark on Potential Recalls, Bans, and Other Risks 5Health News:MSA Schedules First Quarter Earnings Webcast 2Health News:Mice Can Sense Oxygen Through Their Skin 2Health News:Study finds 1 in 5 Iraq and Afghanistan veterans suffer from PTSD or major depression 2Health News:Study finds 1 in 5 Iraq and Afghanistan veterans suffer from PTSD or major depression 3Health News:Study finds 1 in 5 Iraq and Afghanistan veterans suffer from PTSD or major depression 4Health News:Study finds 1 in 5 Iraq and Afghanistan veterans suffer from PTSD or major depression 5
... tilt, user programmable memory two position ... on both chair sides, solid cast ... Single button folding armrests and headrest, ... on both chair sides, ergonomically contoured ...
... chair for examination of the ... adjustable from 540 mm to ... an independent foot switch. The ... and incorporates a multi-adjustable headrest, ...
Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles....
Heine Beta 200 Streak Retinoscope 3.5v...
Medicine Products: